← back to search

Peter D. Schellinger

Johannes Wesling Klinikum Minden ·
Area of research
Epidemiology · Neurology
Research interest
Research interests include Acute Ischemic Stroke Management, Cerebrovascular and Carotid Artery Diseases, Intracerebral and Subarachnoid Hemorrhage Research, and Stroke Rehabilitation and Recovery.
h-index
81
citations
23,311
works
428
NIH funding
primary concept
email

Recent publications

Early surrogates of functional outcome after thrombectomy for MCA-M2 occlusions
Scientific Reports 2026cited by 1position: middledoi
Baseline characteristics of patients with acute ischaemic stroke included in the randomised controlled Find-AF 2 trial
Neurological Research and Practice 2025cited by 2position: middledoi
Endovascular thrombectomy for childhood stroke (Save ChildS Pro): an international, multicentre, prospective registry study
The Lancet Child & Adolescent Health 2024cited by 32position: middledoi
Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism—the Find-AF 2 study—rationale and design
American Heart Journal 2023cited by 24position: middledoi
Predictors of functional outcome after thrombectomy for M2 occlusions: a large scale experience from clinical practice
Scientific Reports 2023cited by 13position: middledoi
Prolonged cardiac monitoring for stroke prevention: A systematic review and meta-analysis of randomized-controlled clinical trials
European Stroke Journal 2022cited by 34position: middledoi
Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-Analysis
Stroke 2022cited by 28position: middledoi
Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE‐SPECT ESUS Trial
Journal of the American Heart Association 2022cited by 15position: middledoi
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data
The Lancet 2020cited by 179position: middledoi
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany—Updated series of 120 cases
International Journal of Stroke 2020cited by 81position: middledoi
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
New England Journal of Medicine 2019cited by 805position: middledoi
European Stroke Organisation (ESO) - European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischemic Stroke
Journal of NeuroInterventional Surgery 2019cited by 562position: middledoi
European Stroke Organisation (ESO) – European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE)
European Stroke Journal 2019cited by 557position: middledoi
Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data
The Lancet 2019cited by 512position: middledoi
European Stroke Organisation (ESO)- European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke
Journal of NeuroInterventional Surgery 2019cited by 463position: middledoi
Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage
JAMA 2019cited by 180position: middledoi
Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11–13 November 2018
European Stroke Journal 2019cited by 171position: middledoi
Medical Management vs Mechanical Thrombectomy for Mild Strokes
JAMA Neurology 2019cited by 138position: middledoi
Intravenous thrombolysis prior to mechanical thrombectomy in large vessel occlusions
Annals of Neurology 2019cited by 105position: middledoi
Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial
The Lancet Neurology 2019cited by 84position: lastdoi
Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves
European Heart Journal 2018cited by 109position: middledoi
Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials
Stroke 2016cited by 111position: middledoi
Combined Lysis of Thrombus with Ultrasound and Systemic Tissue Plasminogen Activator for Emergent Revascularization in Acute Ischemic Stroke (Clotbust-ER): Design and Methodology of a Multinational Phase 3 Trial
International Journal of Stroke 2015cited by 39position: firstdoi
NeuroIntensiv
2015cited by 14position: middledoi
Transcranial Laser Therapy in Acute Stroke Treatment
Stroke 2014cited by 123position: middledoi
Statistical Analysis of the Primary Outcome in Acute Stroke Trials
Stroke 2012cited by 254position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Georgios Tsivgoulis · Hellenic Red Cross4 papers (2015–2022)Guillaume Turc · Université Claude Bernard Lyon 14 papers (2019–2019)Martin Köhrmann · Charité - Universitätsmedizin Berlin4 papers (2015–2022)Danilo Toni · Policlinico Umberto I4 papers (2019–2019)Pooja Khatri · Yale University4 papers (2019–2019)Kyriakos Lobotesis · Imperial College Healthcare NHS Trust3 papers (2019–2019) · 3 papers (2019–2019)Carlos A. Molina · Universidad Mayor de San Andrés3 papers (2015–2022)Joost de Vries · Radboud University Nijmegen3 papers (2019–2019)Urs Fischer · Amsterdam Neuroscience3 papers (2019–2019)Phil White · University of Glasgow3 papers (2019–2019)Mikaël Mazighi · Délégation Paris 53 papers (2019–2019)Andrei V. Alexandrov · Phoenix College3 papers (2015–2019)Jens Fiehler · University of Lübeck3 papers (2019–2019)George Howard · Brown Computer Company (United States)2 papers (2012–2015)Ralph L. Sacco · Lotus Clinical Research2 papers (2019–2022)Lisa Cronin · University of South Florida2 papers (2019–2022)Christopher B. Granger · Duke University2 papers (2019–2022)John Alleman · University of Alabama at Birmingham2 papers (2015–2019)Martina Brueckmann · University Hospital Heidelberg2 papers (2019–2022)